新股暗盤 | 德信服務集團(2215.HK)暗盤段跌逾4%
格隆匯7月14日丨據輝立證券,德信服務集團(2215.HK)暗盤段現報2.93港元,較發行價3.06港元跌4.2%。公司是一家綜合性物業管理服務提供商,2018年至2020年收益分別為3.97億、5.12億、6.92億元人民幣,溢利分別為2246.2萬、5055萬、1.05億元人民幣,每股有形資產淨值0.70-0.89港元,2020歷史市盈率20.78-26.87倍。此次上市,全球發售2.5億股,其中香港發售2500萬股,國際發售2.25億股,每手1000股,一手中籤率75%,香港公開發售獲3.08倍認購,淨籌6.97億港元,當中約65%將用作擴大集團的業務規模及通過多渠道提高市場份額。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.